• Wednesday, May 3, 2023 @ 12:00 am

Cosmo reported record 2022 results and guides 2023 total revenue to increase by 41% to 54% (excluding milestones), boosted by Winlevi and GI Genius. The AI cooperation with Medtronic was extended to host an ecosystem of new apps, including apps from external developers, for GI Genius and accelerate the development cycle.

Key catalysts include:

1. Start phase III trial Breezula in male alopecia (Q2 2023)
2. Winlevi licensing agreements (during 2023)
3. Winlevi filing for EU approval (H2 2023)

Read full Cosmo Valuation Report

You may also be interested in